1CM
VIVE

1492 Capital Management’s VIVEVE MED INC VIVE Stock Holding History

1492 Capital Management’s Portfolio VIVE Stock Details VIVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-15
Closed -$79K – 105
2017
Q3 		$79K Sell
15
-62
-81% -$382K 0.07% 88
2017
Q2 		$554K Sell
77
-1
-1% -$7.45K 0.49% 62
2017
Q1 		$497K Buy
+78
New +$379K 0.39% 64

Other funds holding VIVE

SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return
IG
ING Group Amsterdam, Netherlands $20.5B AUM 49.71% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return

1492 Capital Management's VIVE Position: Q4 2017 in Review

1492 Capital Management sold out of VIVEVE MED INC (VIVE) in Q4 2017, closing a stake of 15 shares — an estimated $79K sold.

1492 Capital Management first reported a position in VIVE in Q1 2017 and held it in 3 quarters. The position peaked at $554K in Q2 2017. 44 funds tracked by Wall St. Rank hold VIVE as of Q4 2017.

  • 1492 Capital Management reported no remaining VIVEVE MED INC position as of Q4 2017 after selling out during the quarter.
  • 1492 Capital Management sold 15 VIVEVE MED INC shares in Q4 2017, an estimated $79K.
  • 1492 Capital Management first reported a position in VIVEVE MED INC in Q1 2017 and held it in 3 quarters.
  • 1492 Capital Management's VIVEVE MED INC position peaked at $554K in Q2 2017.
  • 44 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q4 2017.

Based on 1492 Capital Management's 13F filing for Q4 2017, filed 14 Feb 2018.